TNF and juvenile idiopathic arthritis: Approximately 30–40% of patients with JIA associated NIU are refractory to both methotrexate and TNF inhibitors, experiencing early treatment failure (primary non-response) or loss of response months after starting treatment (secondary non-response) [15].